Last 8.20 INR
Change Today +0.05 / 0.61%
Volume 23.2K
JHSL On Other Exchanges
Symbol
Exchange
Natl India
As of 4:54 AM 10/20/14 All times are local (Market data is delayed by at least 15 minutes).

jhs svendgaard laboratories (JHSL) Snapshot

Open
8.50
Previous Close
8.15
Day High
8.50
Day Low
7.85
52 Week High
09/16/14 - 11.93
52 Week Low
11/29/13 - 4.35
Market Cap
197.6M
Average Volume 10 Days
17.6K
EPS TTM
-5.04
Shares Outstanding
24.1M
EX-Date
12/26/11
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for JHS SVENDGAARD LABORATORIES (JHSL)

Related News

No related news articles were found.

jhs svendgaard laboratories (JHSL) Related Businessweek News

No Related Businessweek News Found

jhs svendgaard laboratories (JHSL) Details

JHS Svendgaard Laboratories Limited manufactures and sells oral care and hygiene products under the Dr. Gold brand name in India and internationally. It also provides contract manufacturing services. The company’s products include toothbrushes, toothpastes, whitening gels, mouthwash, washing powders, whitening mouth rinse, laundry detergents, denture tablets, hand sanitizers, room fresheners, etc. In addition, it is engaged in trading personal care products; and providing dental care services and warehousing/renting services. The company was founded in 1994 and is based in New Delhi, India.

Founded in 1994

jhs svendgaard laboratories (JHSL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jhs svendgaard laboratories (JHSL) Key Developments

JHS Svendgaard Laboratories Ltd., Board Meeting, Aug 21, 2014

JHS Svendgaard Laboratories Ltd., Board Meeting, Aug 21, 2014. Agenda: To consider the approval of un-audited financial results of the company for the first quarter ended on June 30, 2014.

JHS Svendgaard Laboratories Ltd. Announces Management Changes

JHS Svendgaard Laboratories Ltd. has announced that Mr. Ravi Gupta, the Director of the company has resigned from the Directorship of the company with effective from March 04, 2014. The Board of Directors in their meeting held on May 30, 2014 have considered and accepted his resignation. The board in its meeting held on May 30, 2014 has appointed Mr. Paramvir Singh as Chief Executive Officer (CEO) of the company with effective from May 30, 2014. The board in its meeting held on May 30, 2014 has appointed Mr. Neeraj Kumar as Chief Financial Officer (CFO) of the company with effective from April 02, 2014. Mr. Akhilesh Kumar Singh has resigned from the post of Company Secretary of the company and Board of Directors in its meeting held on May 30, 2014 had accepted his resignation with effective from April 21, 2014. The board in its meeting held on May 30, 2014 has appointed Ms. Isha Sablok as Company Secretary of the company, who has assumed the charge with effective from April 22, 2014.

JHS Svendgaard Laboratories Ltd. Reports Consolidated and Standalone Earnings Results for the Fourth Quarter and for the Full Year Ended March 31, 2014

JHS Svendgaard Laboratories Ltd. reported consolidated and standalone earnings results for the fourth quarter and for the full year ended March 31, 2014. For the quarter, the group reported net sales of INR 77.931 million, loss from operations before other income, finance costs, prior period and exceptional items of INR 38.040 million, loss from ordinary activities before tax of INR 108.108 million and net loss after taxes, minority interest of INR 46.496 million or INR 1.93 per diluted share (after extraordinary items) (not-annualised) compared to net sales of INR 110.701 million, loss from operations before other income, finance costs, prior period and exceptional items of INR 23.438 million, loss from ordinary activities before tax of INR 17.158 million and net loss after taxes, minority interest of INR 12.780 million or INR 0.53 per diluted share (after extraordinary items) (not-annualised) reported in the same period last year. For the year, the group reported net sales of INR 349.335 million, loss from operations before other income, finance costs, prior period and exceptional items of INR 185.638 million, loss from ordinary activities before tax of INR 352.933 million and net loss after taxes, minority interest of INR 288.056 million or INR 11.95 per diluted share (after extraordinary items) (not-annualised) compared to net sales of INR 509.714 million, loss from operations before other income, finance costs, prior period and exceptional items of INR 18.284 million, loss from ordinary activities before tax of INR 103.180 million and net loss after taxes, minority interest of INR 37.614 million or INR 1.56 per diluted share (after extraordinary items) (not-annualised) reported in the same period last year. For the quarter, the parent company reported net sales of INR 77.931 million, loss from operations before other income, finance costs, prior period and exceptional items of INR 38.028 million, loss from ordinary activities before tax of INR 108.093 million and net loss of INR 46.481 million or INR 1.93 per diluted share (after extraordinary items) (not-annualised) compared to net sales of INR 110.702 million, loss from operations before other income, finance costs, prior period and exceptional items of INR 32.164 million, loss from ordinary activities before tax of INR 27.115 million and net loss of INR 22.738 million or INR 0.94 per diluted share (after extraordinary items) (not-annualised) reported in the same period last year. For the year, the parent company reported net sales of INR 349.335 million, loss from operations before other income, finance costs, prior period and exceptional items of INR 185.501 million, loss from ordinary activities before tax of INR 352.793 million and net loss of INR 287.916 million or INR 11.95 per diluted share (after extraordinary items) (not-annualised) compared to net sales of INR 474.381 million, loss from operations before other income, finance costs, prior period and exceptional items of INR 21.591 million, loss from ordinary activities before tax of INR 107.659 million and net loss of INR 42.093 million or INR 1.75 per diluted share (after extraordinary items) (not-annualised) reported in the same period last year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JHSL:IN 8.20 INR +0.05

JHSL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for JHSL.
View Industry Companies
 

Industry Analysis

JHSL

Industry Average

Valuation JHSL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.5x
Price/Book 0.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JHS SVENDGAARD LABORATORIES, please visit www.svendgaard.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.